Strategic Analysis of the 2026 Americas Blood Glucose Monitoring Market: CGM Dominance, AI Integration, and Virtual Care Ecosystems
As of February 2026, the Americas Blood Glucose Monitoring (BGM) Market is characterized by a definitive transition from reactive testing to proactive, continuous data streams. The market, which encompasses North America, Latin America, and the Caribbean, is currently dominated by the rapid penetration of Continuous Glucose Monitoring (CGM) systems into the Type 2...
0 Comentários 0 Compartilhamentos 240 Visualizações 0 Anterior